FDA finds no heart attack risk with HIV drug (Reuters)
WASHINGTON (Reuters) – An analysis of 26 clinical trials found no higher risk of heart attacks with AIDS take abacavir compared with other retrovirus medicines, U.S. health officials said on Tuesday.
The Food and Drug Administration reviewed accumulation on abacavir after studies showed inconsistent information about a doable unification to heart attacks.
Abacavir is an fixings in retrovirus drugs Ziagen, Trizivir and Epzicom oversubscribed by ViiV Healthcare, a render stake between GlaxoSmithKline Plc and Pfizer Inc. Glaxo is the eld partner.
The FDA said doctors should move to prescribe abacavir as directed. The agency had disclosed it was reviewing the heart move accumulation in 2008.
Source
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment